These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 19282830

  • 1. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.
    Kuo MC, Liang DC, Huang CF, Shih YS, Wu JH, Lin TL, Shih LY.
    Leukemia; 2009 Aug; 23(8):1426-31. PubMed ID: 19282830
    [Abstract] [Full Text] [Related]

  • 2. Biological Activities of RUNX1 Mutants Predict Secondary Acute Leukemia Transformation from Chronic Myelomonocytic Leukemia and Myelodysplastic Syndromes.
    Tsai SC, Shih LY, Liang ST, Huang YJ, Kuo MC, Huang CF, Shih YS, Lin TH, Chiu MC, Liang DC.
    Clin Cancer Res; 2015 Aug 01; 21(15):3541-51. PubMed ID: 25840971
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY, Huang CF, Lin TL, Wu JH, Wang PN, Dunn P, Kuo MC, Tang TC.
    Clin Cancer Res; 2005 Mar 01; 11(5):1821-6. PubMed ID: 15756005
    [Abstract] [Full Text] [Related]

  • 4. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
    Kim HJ, Ahn HK, Jung CW, Moon JH, Park CH, Lee KO, Kim SH, Kim YK, Kim HJ, Sohn SK, Kim SH, Lee WS, Kim KH, Mun YC, Kim H, Park J, Min WS, Kim HJ, Kim DH, L/MDS working party, Korean Society of Hematology.
    Ann Hematol; 2013 Jan 01; 92(2):163-71. PubMed ID: 23053179
    [Abstract] [Full Text] [Related]

  • 5. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H, Harada H, Harada Y, Ding Y, Imagawa J, Inaba T, Kyo T, Kimura A.
    Leukemia; 2006 Apr 01; 20(4):635-44. PubMed ID: 16467864
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
    Gelsi-Boyer V, Trouplin V, Roquain J, Adélaïde J, Carbuccia N, Esterni B, Finetti P, Murati A, Arnoulet C, Zerazhi H, Fezoui H, Tadrist Z, Nezri M, Chaffanet M, Mozziconacci MJ, Vey N, Birnbaum D.
    Br J Haematol; 2010 Nov 01; 151(4):365-75. PubMed ID: 20880116
    [Abstract] [Full Text] [Related]

  • 12. Proleukemic RUNX1 and CBFbeta mutations in the pathogenesis of acute leukemia.
    Engel ME, Hiebert SW.
    Cancer Treat Res; 2010 Nov 01; 145():127-47. PubMed ID: 20306249
    [Abstract] [Full Text] [Related]

  • 13. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C, Fermo E, Corti S, Molteni M, Faricciotti A, Cortelezzi A, Lambertenghi Deliliers G, Beran M, Onida F.
    Clin Cancer Res; 2010 Apr 15; 16(8):2246-56. PubMed ID: 20371679
    [Abstract] [Full Text] [Related]

  • 14. Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
    Pérez B, Kosmider O, Cassinat B, Renneville A, Lachenaud J, Kaltenbach S, Bertrand Y, Baruchel A, Chomienne C, Fontenay M, Preudhomme C, Cavé H.
    Br J Haematol; 2010 Dec 15; 151(5):460-8. PubMed ID: 20955399
    [Abstract] [Full Text] [Related]

  • 15. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
    Taketani T, Taki T, Takita J, Tsuchida M, Hanada R, Hongo T, Kaneko T, Manabe A, Ida K, Hayashi Y.
    Genes Chromosomes Cancer; 2003 Sep 15; 38(1):1-7. PubMed ID: 12874780
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease.
    Wang SA, Galili N, Cerny J, Sechman E, Chen SS, Loew J, Liu Q, Fadare O, Hasserjian R, Jones D, Qawi H, Woda B, Raza A.
    Am J Clin Pathol; 2006 Nov 15; 126(5):789-97. PubMed ID: 17050076
    [Abstract] [Full Text] [Related]

  • 19. RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia.
    Bera R, Chiu MC, Huang YJ, Lin TH, Kuo MC, Shih LY.
    J Hematol Oncol; 2019 Oct 22; 12(1):104. PubMed ID: 31640815
    [Abstract] [Full Text] [Related]

  • 20. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
    Wang J, Wang T, Li S, Lin L, Gang Y.
    Ai Zheng; 2007 Jan 22; 26(1):58-63. PubMed ID: 17222369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.